Welcome to our dedicated page for Exponent news (Ticker: EXPO), a resource for investors and traders seeking the latest updates and insights on Exponent stock.
The EXPO news page on Stock Titan aggregates recent press releases and market-moving updates related to Exponent, Inc., a science and engineering consulting firm listed on Nasdaq. Exponent reports regularly on its financial results, business trends across its engineering and other scientific segment and its environmental and health segment, and developments in the industries it serves. These updates often include commentary on dispute-related engagements, proactive risk management projects, and regulatory consulting work.
Investors following EXPO news can review quarterly earnings releases that discuss revenues before reimbursements, operating income, net income, and non-GAAP measures such as EBITDA and EBITDAS. Management commentary provides context on demand in sectors such as construction, automotive, medical devices, chemicals, transportation, utilities, life sciences, consumer electronics, and consumer products. Releases also describe how Exponent’s multidisciplinary teams address issues like failure analysis, asset integrity, digital health, artificial intelligence usability, and distributed energy systems.
In addition to earnings, Exponent’s news flow includes announcements about regular quarterly cash dividends and share repurchase authorizations. The company has reported dividend declarations for multiple quarters and increases to its stock repurchase program, offering insight into its capital allocation approach. Other items covered in EXPO news include scheduling and access details for quarterly conference calls and webcasts where executives discuss business performance and outlook.
By monitoring the EXPO news page, readers can track how Exponent’s two operating segments perform over time, how demand is evolving across the industries it serves, and how the company uses dividends and repurchases alongside investment in talent and capabilities. This page is a convenient way to review Exponent’s official communications and financial updates in one place.
Exponent (NASDAQ: EXPO) reported strong Q4 and fiscal year 2024 results, with total Q4 revenues increasing 11.3% to $136.8 million and revenues before reimbursements rising 8.7% to $123.8 million. Q4 net income grew to $23.6 million ($0.46 per diluted share), up from $20.9 million ($0.41 per diluted share) in Q4 2023.
For fiscal year 2024, total revenues increased 4.1% to $558.5 million, with net income reaching $109.0 million ($2.11 per diluted share). The company achieved growth across both proactive and reactive services, particularly in consumer electronics, utilities, and medical devices. EBITDA margin improved to 28.4% of revenues before reimbursements.
The company increased its quarterly dividend from $0.28 to $0.30 and ended the year with $258.9 million in cash. Looking ahead to 2025, Exponent expects low single-digit revenue growth despite a 5-6% headwind in technical full-time-equivalent employees.
Exponent (NASDAQ: EXPO) has scheduled its Fourth Quarter and fiscal year 2024 financial results announcement for Thursday, February 6, 2025, after market close. The company will host a conference call and webcast at 4:30 p.m. ET (1:30 p.m. PT) on the same day.
CEO and President Dr. Catherine Corrigan and CFO Richard Schlenker will lead the discussion of the company's business and financial results for the period ended January 3, 2025. Investors can access the live call through designated phone numbers or view the webcast through Exponent's Investor Relations website. A telephonic replay will be available until February 13, 2025.
Exponent (Nasdaq: EXPO) has declared a quarterly cash dividend of $0.28 per share for Q4 2024, payable on December 20, 2024, to stockholders of record as of December 6, 2024. The company maintains its quarterly dividend schedule in March, June, September, and December, subject to Board approval. CEO Dr. Catherine Corrigan emphasized the company's commitment to shareholders, highlighting their diverse services portfolio and aligned operating model as key factors in capturing market demand and delivering long-term value.
Exponent (NASDAQ: EXPO) reported Q3 2024 financial results with flat revenues before reimbursements at $125.1 million, while total revenues increased 2% to $136.3 million. Net income grew 6% to $26.0 million ($0.50 per diluted share), and EBITDA margin expanded by 100 basis points to 28.6%. The company saw healthy rebound in consumer electronics sector, offset by challenges in chemicals. Year-to-date results showed 3% growth in revenues before reimbursements to $394.7 million, with net income of $85.4 million ($1.66 per diluted share). The company maintained revenue guidance and raised margin guidance for full-year 2024.
Exponent, Inc. (Nasdaq: EXPO) has announced it will report its Third Quarter of fiscal year 2024 financial results on Thursday, October 24, 2024, after market close. The results will cover the period ended September 27, 2024. Following the release, the company will host a conference call and webcast at 4:30 p.m. ET (1:30 p.m. PT) to discuss the business and financial results.
The call will be led by Dr. Catherine Corrigan, CEO and President, and Richard Schlenker, Executive VP and CFO. Investors can join the live call at (844) 481-2781 or (412) 317-0672. A live and archived webcast will be available from the Investor Relations section of Exponent's website. A telephonic replay will be accessible until October 31, 2024, by dialing (877) 344-7529 or (412) 317-0088 with passcode 1389454#.
Exponent, Inc. (Nasdaq: EXPO) has declared a quarterly cash dividend of $0.28 per share of common stock, payable on September 20, 2024, to stockholders of record as of September 6, 2024. The company maintains its practice of paying quarterly dividends in March, June, September, and December. Dr. Catherine Corrigan, President and CEO, emphasized Exponent's commitment to shareholders through this dividend, citing strong market drivers and strategic positioning as enablers of sustainable long-term growth. Future dividend declarations remain subject to the Board of Directors' final determination.
Exponent, Inc. (Nasdaq: EXPO) reported its Q2 2024 financial results, showing flat total revenues at $140.5 million and a 2% increase in revenues before reimbursements to $132.4 million. Net income grew 14% to $29.2 million, or $0.57 per diluted share. EBITDA increased to $39.9 million, representing 30.2% of revenues before reimbursements. The company's engineering and scientific segment, accounting for 84% of revenues, grew 4% in Q2. Despite challenges in consumer electronics and chemicals sectors, Exponent saw growth in transportation, utilities, and medical device sectors. The company raised its full-year 2024 guidance, expecting low to mid-single digit growth in revenues before reimbursements and EBITDA to be 27.5% to 28.0% of revenues before reimbursements.
Exponent (Nasdaq: EXPO) will announce its financial results for the second quarter of fiscal year 2024 on July 25, 2024, after the market closes. The results cover the period ending June 28, 2024. On the same day, CEO Dr. Catherine Corrigan and CFO Richard Schlenker will host a conference call and webcast at 4:30 p.m. ET to discuss the company's business and financial performance. Interested parties can join the live call by dialing (844) 481-2781 or (412) 317-0672, and a replay will be available until August 1, 2024, by dialing (877) 344-7529 or (412) 317-0088 with passcode 2296670#. Both the live and archived webcast will be accessible via Exponent's Investor Relations webpage.
Summary not available.
Summary not available.
FAQ
What is the current stock price of Exponent (EXPO)?
What is the market cap of Exponent (EXPO)?
